House committee tells FDA to suspend lab developed test rule
Lawmakers said the final rule carries “the risk of greatly altering the United States’ laboratory testing infrastructure.”
Lawmakers said the final rule carries “the risk of greatly altering the United States’ laboratory testing infrastructure.”